Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06184009 |
| Consolidated Lead Sponsor | Jae Wook Lee |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 370 participants (ESTIMATED) |
| Registered Start Date | 2024-08-10 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Seoul National University Hospital | Seoul, South Korea | Open Hospital Dossier -> |
| Samsung Medical Center | Seoul, South Korea | Open Hospital Dossier -> |
| Inha University Hospital | Incheon, South Korea | Open Hospital Dossier -> |
| Korea University Anam Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.